Formica, V.; Morelli, C.; Conca, V.; Calegari, M.A.; Lucchetti, J.; Dell’Aquila, E.; Schirripa, M.; Messina, M.; Salvatore, L.; Lo Prinzi, F.;
et al. Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers 2023, 15, 3064.
https://doi.org/10.3390/cancers15113064
AMA Style
Formica V, Morelli C, Conca V, Calegari MA, Lucchetti J, Dell’Aquila E, Schirripa M, Messina M, Salvatore L, Lo Prinzi F,
et al. Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers. 2023; 15(11):3064.
https://doi.org/10.3390/cancers15113064
Chicago/Turabian Style
Formica, Vincenzo, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell’Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi,
and et al. 2023. "Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis" Cancers 15, no. 11: 3064.
https://doi.org/10.3390/cancers15113064
APA Style
Formica, V., Morelli, C., Conca, V., Calegari, M. A., Lucchetti, J., Dell’Aquila, E., Schirripa, M., Messina, M., Salvatore, L., Lo Prinzi, F., Dima, G., Trovato, G., Riondino, S., Roselli, M., Skoulidis, F., Arkenau, H.-T., & Cremolini, C.
(2023). Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers, 15(11), 3064.
https://doi.org/10.3390/cancers15113064